CIK 0000925741 · Non-accelerated filer<br>Smaller reporting company
BioCardia, Inc.
Sign in to watch- Ticker
- BCDA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 232753988
- Phone
- 650-226-0123
- Business address
- 320 SOQUEL WAY, SUNNYVALE, CA, 94085
- Former names
- Tiger X Medical, Inc., Cardo Medical, Inc., CLICKNSETTLE COM INC, NAM CORP
- 4 Open-market buy President and CEO bought 4,300 shares at an average $0.87 ($3,754)
- 4 Open-market buy President and CEO bought 7,500 shares at an average $0.96 ($7,175)
- 4 Open-market buy President and CEO bought 5,400 shares at $0.96 ($5,208)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Shares withheld for taxes President and CEO gave up 54,606 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Financial Officer gave up 23,125 shares (to pay taxes)
- 4 Shares withheld for taxes Senior Vice President, Devices gave up 17,269 shares (to pay taxes)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Grant or award President and CEO acquired 110,625 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 60,483 shares (grant or award)
- 4 Grant or award Senior Vice President, Devices acquired 39,521 shares (grant or award)
- 4 Open-market buy Director bought 109,200 shares at an average $0.95 ($103,584)
- 4 Open-market buy President and CEO bought 2,300 shares at an average $0.89 ($2,043)
- 8-K Event Regulation FD disclosure
- 8-K Event Delisting notice
- 4 Open-market buy President and CEO bought 5,000 shares at $0.85 ($4,250)
Page 2 of 58 · 1,160 filings